Show
Sort by
-
- Journal Article
- A1
- open access
Respiratory viruses in patients with hematological malignancy in boreal autumn/winter 2023–2024 : EPICOVIDEHA-EPIFLUEHA report
-
- Journal Article
- A1
- open access
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic : results from the epicovideha registry
-
- Journal Article
- A1
- open access
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients : results from the EPICOVIDEHA registry
-
- Journal Article
- A1
- open access
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies : results from the EPICOVIDEHA survey
-
- Journal Article
- A1
- open access
Decoding the historical tale : COVID-19 impact on haematological malignancy patients : EPICOVIDEHA insights from 2020 to 2022
-
- Journal Article
- A1
- open access
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19 : matched-paired analysis in the EPICOVIDEHA registry
-
- Journal Article
- A1
- open access
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies : a report from the EPICOVIDEHA registry
-
- Journal Article
- A1
- open access
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients : EPICOVIDEHA findings
-
- Journal Article
- A1
- open access
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection : a European Hematology Association Survey (EPICOVIDEHA)
-
- Journal Article
- A1
- open access
Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies : an EPICOVIDEHA survey report